GT BIOPHARMA, INC. ANNOUNCES ADDITIONAL POSITIVE DATA FROM ITS PHASE 1 CLINICAL TRIAL FOR MYASTHENIA GRAVIS AND POTENTIAL FOR ACCELERATION OF THE START OF ITS PHASE 2 TRIAL

WASHINGTON, DC / MARCH 26, 2018 / GT Biopharma Inc. (OTCQB “GTBP”…

GrowLife, Inc. (PHOT) Launches Line of Eco-Friendly Products

GrowLife, Inc. Launches Line of Eco-Friendly Products to Meet Growing Demand for…

Tetra Bio-Pharma Inc. (TBPMF) Announces FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome

Tetra Bio-Pharma Announces FDA Orphan Drug Designation for PPP001 in Treatment of…

Cannabis Science, Inc., (CBIS) Announces Beta Launch of iCannabinoid

Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana…

Tetra Bio-Pharma Inc. (TBPMF) & Neptune Technologies (NEPT.TO) Enter Co-Development Agreement

Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products…

Aurora Cannabis Inc. (ACBFF) Launches Aurora PRO Corporate Account Program

Aurora Cannabis Launches Aurora PRO Corporate Account Program Aurora Cannabis Inc. (“Aurora”)…

Marijuana Growers Are Challenging California’s Grow Regulations

To fight against the future threat of marijuana corporatization, marijuana cultivators in…

Digipath, Inc. (DIGP) Resumes Testing Operations Following Reinstatement of Nevada Licenses

Digipath Labs Resumes Testing Operations Following Reinstatement of Nevada Licenses Digipath, Inc. (DIGP),…